These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9184676)

  • 21. Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats.
    Wang J; Dunn MJ
    Am J Physiol; 1987 Dec; 253(6 Pt 2):F1283-9. PubMed ID: 2827506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs.
    Abu-Zidan FM; Walther S
    Eur J Surg; 1996 Jun; 162(6):499-504. PubMed ID: 8817228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs.
    Kruse-Elliott KT
    Am J Vet Res; 1997 Dec; 58(12):1386-91. PubMed ID: 9401686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of adrenal steroids in the recovery from platelet activating factor challenge.
    Myers AK; Bader TJ
    Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
    Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats.
    Kitagawa S; Kubota Y; Yamaguchi T; Fujimura K; Binnaka T; Tani K; Ogura M; Mizuno T; Inoue K
    J Gastroenterol Hepatol; 1992; 7(5):481-5. PubMed ID: 1391729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethanol suppresses endotoxin but not platelet activating factor-induced hypotension and nitric oxide.
    Greenberg SS; Xie J; Powers DR; Giles TD
    Alcohol Clin Exp Res; 1996 Oct; 20(7):1260-8. PubMed ID: 8904980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of lung injury by platelet-activating factor antagonism in nonhypotensive porcine endotoxemia.
    Abu-Zidan FM; Walther S; Lennquist S
    Circ Shock; 1994 Nov; 44(3):148-53. PubMed ID: 7600638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal ischemia in the newborn: the role of intestinal maturation.
    Musemeche CA; Pizzini RP; Andrassy RJ
    J Surg Res; 1993 Dec; 55(6):595-8. PubMed ID: 8246492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is platelet activating factor (PAF) a mediator of endotoxin shock?
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Eur J Pharmacol; 1985 Feb; 109(2):257-61. PubMed ID: 3996473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats.
    Qu XW; Rozenfeld RA; Huang W; Crawford SE; Gonzalez-Crussi F; Hsueh W
    J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):227-34. PubMed ID: 9729632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endotoxaemia in rats: role of NO, PAF and TXA2 in pulmonary neutrophil sequestration and hyperlactataemia.
    Olszanecki R; Chłopicki S
    J Physiol Pharmacol; 1999 Sep; 50(3):443-54. PubMed ID: 10574473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.
    Gonzalez-Crussi F; Hsueh W
    Am J Pathol; 1983 Jul; 112(1):127-35. PubMed ID: 6859226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of plasma level of platelet activating factor in cirrhotic patients and its relation to endotoxemia].
    Zeng N
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):141-3, 189. PubMed ID: 1319804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxin, PAF and arterial thrombosis.
    Bourgain RH; Andries R; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S187-93. PubMed ID: 2133281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor modulates activity of cyclic nucleotides in fetal ovine pulmonary vascular smooth muscle.
    Ibe BO; Ameer A; Portugal AM; Renteria L; Raj JU
    J Pharmacol Exp Ther; 2007 Feb; 320(2):728-37. PubMed ID: 17085546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor-induced increases in glucose kinetics.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E193-200. PubMed ID: 3348371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia.
    Tsuchiya R; Kyotani K; Scott MA; Nishizono K; Ashida Y; Mochizuki T; Kitao S; Yamada T; Kobayashi K
    Am J Vet Res; 1999 Feb; 60(2):216-21. PubMed ID: 10048555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of platelet-activating factor (PAF) and prostaglandins in colonic motor and secretory disturbances induced by Escherichia coli endotoxin in conscious rats.
    Pons L; Droy-Lefaix MT; Buéno L
    Prostaglandins; 1994 Feb; 47(2):123-36. PubMed ID: 8016383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.